[Malaria and intestinal protozoa]

Enferm Infecc Microbiol Clin. 2016 Mar;34(3):191-204. doi: 10.1016/j.eimc.2015.12.009. Epub 2016 Jan 28.
[Article in Spanish]

Abstract

Malaria is life threatening and requires urgent diagnosis and treatment. Incidence and mortality are being reduced in endemic areas. Clinical features are unspecific so in imported cases it is vital the history of staying in a malarious area. The first line treatments for Plasmodium falciparum are artemisinin combination therapies, chloroquine in most non-falciparum and intravenous artesunate if any severity criteria. Human infections with intestinal protozoa are distributed worldwide with a high global morbid-mortality. They cause diarrhea and sometimes invasive disease, although most are asymptomatic. In our environment populations at higher risk are children, including adopted abroad, immune-suppressed, travelers, immigrants, people in contact with animals or who engage in oral-anal sex. Diagnostic microscopic examination has low sensitivity improving with antigen detection or molecular methods. Antiparasitic resistances are emerging lately.

Keywords: Artemisinin; Artemisininas; Diarrea; Diarrhea; Intestinal protozoa; Malaria; Protozoos intestinales.

MeSH terms

  • Animals
  • Antimalarials / therapeutic use
  • Chloroquine / therapeutic use
  • Humans
  • Incidence
  • Intestines / parasitology*
  • Malaria, Falciparum / drug therapy
  • Malaria, Falciparum / epidemiology*

Substances

  • Antimalarials
  • Chloroquine